Endothelial TGFβ signaling modulates choroidal neovascularization severity via myeloid–endothelial cell interaction - Report - MDSpire

Endothelial TGFβ signaling modulates choroidal neovascularization severity via myeloid–endothelial cell interaction

  • By

  • Anja Schlecht

  • Lisa Müllerbauer

  • Katja Fitz

  • Bianka Brunne

  • Nico Hofmann

  • Christian Müller

  • Jost Hillenkamp

  • Süleyman Ergün

  • Andreas Neueder

  • Barbara M. Braunger

  • June 26, 2026

  • 0 min

Share

TGFβ Signaling in Endothelial Cells Influences Choroidal Neovascularization

Overview

This study investigates the role of endothelial TGFβ signaling in choroidal neovascularization (CNV) and its interaction with mononuclear phagocytes (MP). Loss of endothelial TGFβ signaling exacerbates CNV, but this effect can be rescued by MP depletion.

Background

Choroidal neovascularization (CNV) is a key feature of neovascular age-related macular degeneration (nAMD), leading to severe vision loss. The integrity of the blood-retinal barrier (BRB) is crucial for retinal health, and its disruption is implicated in the pathogenesis of CNV. Understanding the molecular mechanisms, including TGFβ signaling, that regulate CNV is important.

Data Highlights

No numerical data presented in the article.

Key Findings

  • Loss of endothelial TGFβ signaling significantly exacerbates CNV in a mouse model.
  • Depletion of mononuclear phagocytes (MP) fully rescues the exacerbated CNV due to TGFβ signaling loss.
  • Fibrinogen alpha chain (Fga) is identified as a MP-derived factor upregulated in the absence of endothelial TGFβ signaling.
  • Endothelial TGFβ signaling interacts with microglia to promote angiogenesis.
  • Microglia accumulation is observed at CNV lesions in mice lacking endothelial TGFβ signaling.

Clinical Implications

The findings indicate a relationship between TGFβ signaling pathways and CNV in nAMD.

Conclusion

This research highlights the role of endothelial TGFβ signaling in regulating CNV through interactions with mononuclear phagocytes.

Related Resources & Content

  1. American Academy of Ophthalmology, Ophthalmology, 2024 -- Age-Related Macular Degeneration Preferred Practice Pattern®
  2. Retinal Physician, 2011 -- Ocular Angiogenesis: The Science Behind the Symptoms
  3. Blood Cancer Journal, 2017 -- Malignant T cells induce activation of endothelial cells through IL-17F
  4. Frontiers in Immunology, 2026 -- Comprehensive analysis of the TGF-β signaling pathway: molecular mechanisms, disease drivers, and frontiers in clinical translation
  5. Frontiers in Medicine — PBMC-derived FGF, PDGF, VEGF and GM-CSF secretion in endometriosis: a case–control in vitro study
  6. Age-Related Macular Degeneration Preferred Practice Pattern® - Ophthalmology
  7. Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Trial - ScienceDirect
  8. Aflibercept 8⠋mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panel

Original Source(s)

Related Content